Tonix Pharmaceuticals Holding Corp.

Ownership Transactions Reported by 13 Insiders

Symbol
TNXP on Nasdaq
Location
26 Main Street, Suite 101, Chatham, NJ

There are no Buy or Sell transactions made by insiders since 4/23/2024

Tonix Pharmaceuticals Holding Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel Wintner Goodman Director $8.55K May 25, 2021
Seth Lederman Chief Executive Officer, Director $20.00 Feb 5, 2025
Adeoye Olukotun Director $0 Jun 10, 2024
Margaret Smith Bell Director $0 Feb 5, 2025
Siobhan Fogarty Chief Technology Officer $0 Feb 25, 2025
James Treco Director $0 Feb 5, 2025
Richard H. Bagger Director $0 Feb 5, 2025
Gregory M. Sullivan Chief Medical Officer $0 Feb 5, 2025
Bradley Saenger Chief Financial Officer $0 Feb 5, 2025
David L. Grange Director May 23, 2024
Carolyn E. Taylor Director May 23, 2024
Jessica Morris Chief Operating Officer Feb 5, 2025
Richard Newcomb Stillwell Director May 23, 2024

Recent Insider Transactions by Companies or Individuals for Tonix Pharmaceuticals Holding Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.